Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Open accessThe DOI matches its Crossref record; 135 of the 136 references it cites were found in a registry or an index.
Abstract
The state of the art in identifying protein–protein interaction inhibitors of hypoxia inducible factor – a promising target for anticancer drug design – is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One of the most commonly used PPI inhibitors and E3 ligase ligands is derived from a PTM bearing peptide, hydroxylated HIF-1α [33], thus proving the possibility of developing inhibitors for this type of interaction.”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedRETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Research works printed but not linked: 2
- Zhong, 1999, Cancer Res., 59, 5830
- Burslem, 2014, Synlett, 25, 324
Cited by
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
Burslem, G. M., & Crews, C. M. (2020) · Cell · doi:10.1016/j.cell.2019.11.031 · Cited by 1,079
“Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction.”
InfluentialSelf-citationTargeting hypoxia-inducible factors: therapeutic opportunities and challenges
Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00848-6 · Cited by 245
“Furthermore, considerable effort has been made to identify inhibitors that disrupt the binding of HIF1α with p300, as summarized in a recent review article 150 .”
Wang, H., Dawber, R. S., Zhang, P., Walko, M., Wilson, A. J., & Wang, X. (2021) · Chemical Science · doi:10.1039/d1sc00165e · Cited by 153
Self-citationFlavonoids Targeting HIF-1: Implications on Cancer Metabolism
Samec, M., Líšková, A., Koklesová, L., Meršaková, S., Strnádel, J., Kajo, K., Péč, M. J., Zhai, K., Šmejkal, K., Mirzaei, S., et al. (2021) · Cancers · doi:10.3390/cancers13010130 · Cited by 123
“Structurally, HIF-1 is a heterodimeric protein composed of HIF-α and HIF-β subunits [19].”
BackgroundSousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A., & Heather, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.024 · Cited by 112
Predicting and Experimentally Validating Hot-Spot Residues at Protein–Protein Interfaces
Ibarra, A. Á., Bartlett, G. J., Hegedüs, Z., Dutt, S., Hóbor, F., Horner, K. A., Hetherington, K., Spence, K., Nelson, A. S., Edwards, T. A., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00560 · Cited by 109
Self-citationHypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer
Akanji, M. A., Rotimi, D., & Adeyemi, O. S. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8547846 · Cited by 76
“EZN-2968 is a RNA modulator composed of synthetic antisense oligonucleotide that binds and inhibits specifically the HIF-1α mRNA expression [6, 58].”
BackgroundMorris, D. R., Qu, Y., Agrawal, A. S., Garofalo, R. P., & Casola, A. (2020) · Viruses · doi:10.3390/v12101088 · Cited by 48
“In the nucleus, HIF-α dimerizes with HIF-1β to form a complete HIF-1 complex that then recognizes hypoxia-response elements (HREs) to control target gene expression [8,10].”
BackgroundProtein Recognition by Functionalized Sulfonatocalix[4]arenes
Doolan, A. M., Rennie, M. L., & Crowley, P. B. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201704931 · Cited by 42
Li, J., Xi, W., Li, X., Sun, H., & Li, Y. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.042 · Cited by 42
Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction
Situmorang, G. R., & Sheerin, N. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3940-4 · Cited by 36
“Whereas the β sub-unit is relatively insensitive to alteration in oxygen levels, the level of the alpha sub-unit (HIF-α) is highly dependent on cellular oxygen tension [11, 12].”
BackgroundBall, A. T., Mohammed, S., Doigneaux, C., Gardner, R. M., Easton, J. W., Turner, S. J., Essex, J. W., Pairaudeau, G., & Tavassoli, A. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c10508 · Cited by 35
Harati‐Sadegh, M., Kohan, L., Teimoori, B., Mehrabani, M., & Salimi, S. (2018) · Placenta · doi:10.1016/j.placenta.2018.05.005 · Cited by 30
Mushroom: A New Resource for Anti-Angiogenic Therapeutics
Jana, P., & Acharya, K. (2020) · Food Reviews International · doi:10.1080/87559129.2020.1721529 · Cited by 31
“1α is a promiscuous transcription factor and activates different target genes through the binding with HIF responsive elements (HRE), the promoter region of these genes.([15]) At low oxygen pressure, HIF induces the synthesis of angiogenic pathway regulator micro RNAs (miR) which are designated with the term HypoxamiR.”
BackgroundPotent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2
Qin, X., Chen, H., Tu, L., Ma, Y., Liu, N., Zhang, H., Li, D., Riedl, B., Bierer, D. E., Yin, F., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01043 · Cited by 27
Martin, A. R., Ronco, C., Demange, L., & Benhida, R. (2016) · MedChemComm · doi:10.1039/c6md00432f · Cited by 30
Metabolic switch in cancer – Survival of the fittest
Raskov, H., Gaggar, S., Tajik, A., Orhan, A., & Gögenür, I. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.025 · Cited by 26
Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery
Stoica, S. I., Bleoţu, C., Ciobanu, V., Ionescu, A. M., Albadi, I., Onose, G., & Munteanu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020481 · Cited by 23
“At the same time, the oxygen-dependent hydroxylation, performed by FIH to arginine residue of HIF-1α C-terminal transactivation domain (CAD), cancels the HIF-1α interaction with p300, preventing its translational activity [27,30].”
BackgroundJiang, W., Abdulkadir, S., Zhao, X., Sang, P., Τοματσίδου, Α., Zhang, X., Chen, Y., Calcul, L., Sun, X., Cheng, F., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06694 · Cited by 25
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Self-citationBruno, G., Bergolis, V. L., Piscazzi, A., Crispo, F., Condelli, V., Zoppoli, P., Maddalena, F., Pietrafesa, M., Giordano, G., Matassa, D. S., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5369 · Cited by 22
“The major transcriptional regulator of adaptive responses to hypoxia is the hypoxia inducible factor 1 (HIF‐1), a heterodimeric complex composed of HIF‐1α and HIF‐1β/Aryl hydrocarbon receptor nuclear translocator (7,8).”
BackgroundHetherington, K., Hegedüs, Z., Edwards, T. A., Sessions, R. B., Nelson, A. S., & Wilson, A. J. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202000417 · Cited by 15
Self-citationDiscovery of bicyclo[3,3,1]non-2-ene as a novel skeleton for HIF-1 inhibitors
Ueda, H., Yoshimori, A., & Nakamura, H. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.05.002 · Cited by 13
Interfacial Peptides as Affinity Modulating Agents of Protein-Protein Interactions
Ershov, P. V., Mezentsev, Y. V., & Ivanov, A. S. (2022) · Biomolecules · doi:10.3390/biom12010106 · Cited by 12
A divergent mode of activation of a nitrosyl iron complex with unusual antiangiogenic activity
Carvalho, E. M., Ridnour, L. A., Júnior, F. S. G., Cabral, P. H. B., do Nascimento, N. R. F., Wink, D. A., Franco, D. W., de Medeiros, M. J. C., Pontes, D. D. L., Longhinotti, E., et al. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111133 · Cited by 10
Understanding p300-transcription factor interactions using sequence variation and hybridization
Hóbor, F., Hegedüs, Z., Ibarra, A. Á., Petrovicz, V. L., Bartlett, G. J., Sessions, R. B., Wilson, A. J., & Edwards, T. A. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00026a · Cited by 11
Self-citationDevi, D., Sharma, K., Khan, T., Rani, H., Rana, R., Sharma, H., Kaur, P., Prajapati, L., Rizwan, A., Allieu, M., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156271 · Cited by 13
Shimizu, T., Takahashi, N., Huber, V. J., Asawa, Y., Ueda, H., Yoshimori, A., Muramatsu, Y., Seimiya, H., Kouji, H., Nakamura, H., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115949 · Cited by 10
Almasi, S., SarmastiEmami, S., Baird, S. D., Ning, Z., Figeys, D., Côté, J., Cowan, K. N., & Jasmin, B. J. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04969-4 · Cited by 9
“Direct binding of HIF2α to the hypoxia response elements in the promotor region of target genes activate their transcription and ultimately leads to increases in mRNA and protein expression [40, 41].”
BackgroundDoi, T., Umedera, K., Miura, K., Morita, T., & Nakamura, H. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob01534c · Cited by 4
Engineered coiled-coil HIF1α protein domain mimic
Britton, D., Katsara, O., Mishkit, O., Wang, A., Pandya, N., Liu, C., Mao, H., Legocki, J., Jia, S., Xiao, Y., et al. (2024) · Biomaterials Science · doi:10.1039/d4bm00354c · Cited by 3
Imaging the Hypoxic Tumor Microenvironment in Cancer Models
Parihar, A., Sharma, P., Sharma, M., & Khan, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_15 · Cited by 3
Helical sulfonyl-γ-AApeptides for the inhibition of HIV-1 fusion and HIF-1α signaling
Zhao, X., Liu, H., Zhang, J. C., & Cai, J. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00110a · Cited by 2
Yazdani, B., Wing, P. A. C., Enguita, F. J., & Sirous, H. (2022) · Preprints.org · doi:10.20944/preprints202202.0349.v1 · Cited by 2
Joshi, E., Pandya, M. D., Balar, S., Saiyed, H., Patel, S., Rawal, R., & Desai, U. (2023) · Research Square · doi:10.21203/rs.3.rs-3039736/v1 · Cited by 2
Site-directed allostery perturbation to probe the negative regulation of hypoxia inducible factor-1α
Petrovicz, V. L., Pasztuhov, I., Martinek, T. A., & Hegedüs, Z. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00066h · Cited by 1
“11 In hypoxia, the a subunit of HIF-1 (HIF-1 a ) translocates to the nucleus and interacts with the HIF-1 b subunit, forming HIF-1.”
BackgroundAssessment of the Toxicity of Polystyrene Microplastic in the Colon and Liver of Adult NMRI Mice
Zangene, S., Morovvati, H., Anbara, H., & Bernabò, N. (2025) · Iranian Journal of Veterinary Medicine · doi:10.32598/ijvm.19.2.1005532
“Besides β-catenin, hypoxia-inducible factor 1-alpha (HIF-1α) is crucial for mammal tumor growth (Burslem et al., 2017).”
BindingDB (2025) · UC San Diego · doi:10.7270/q24j0kvm
Metadata
- Authors
- Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J.
- Affiliations
- University of Leeds (GB)
- Corresponding author
- Wilson, Andrew J.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 8
- Issue
- 6
- Pages
- 4188-4202
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC5576430
- OpenAlex
- W2608188974
- Cited by
- 39
- References
- 136
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 1
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Update notices
- Open access
- diamond
- doi.org
- Locations
- Chemical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- European Research Council (ERC-StG-240324, ERC-PoC 632207)
- EPSRC (EP/N025652/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- hypoxia-inducible factor, protein-protein interaction, HIF inhibition, cancer chemotherapy, tumor hypoxia, tumor angiogenesis, HIF-1α, HIF-2α, oncology drug targets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.